Mazaro NV Quote - MLMAZ | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
Europe
EU
Mazaro NV (MLMAZ) Share Price

Mazaro NV (MLMAZ)

3.00

0.00

(0.00%)

Closed 14 October 2:30AM

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

3.00

Bid

3.00

Offer

4.00

Volume

0.00

0.00 Day's Range 0.00

1.50 52 Week Range 5.50

Market Cap

Previous Close

3.00

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

6

Shares Outstanding

83,000

Dividend Yield

-

PE Ratio

-0.34

Earnings Per Share (EPS)

-8.89

Revenue

36k

Net Profit

-738k

Sector

Motor Vehicle Part,accessory

Industry

Motor Vehicle Part,accessory

Website

www.mazaro.eu

Headquarters

Ghent, East Flanders, Bel

Founded

-

Mazaro NV is listed in the Motor Vehicle Part,accessory sector of the Euronext with ticker MLMAZ. The last closing price for Mazaro NV was 3.00 €. Over the last year, Mazaro NV shares have traded in a share price range of 1.50 € to 5.50 €.

Mazaro NV currently has 83,000 shares in issue. The market capitalisation of Mazaro NV is 249,000.00 € . Mazaro NV has a price to earnings ratio (PE ratio) of -0.34.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	3	3	3	7	3	DE
4	0	0	3	3	3	3	3	DE
12	-0.9	-23.0769230769	3.9	4	3	6	3.83832335	DE
26	0	0	3	4	2.5	9	3.4116905	DE
52	-2.5	-45.4545454545	5.5	5.5	1.5	20	4.06115641	DE
156	-2.5	-45.4545454545	5.5	10.25	1.5	84	7.14592539	DE
260	-2.5	-45.4545454545	5.5	10.25	1.5	84	7.14592539	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ALRPDRapid Nutrition	0.0746 € (28.18%)	15.67M
ALOKWGroupe Okwind SA	8.20 € (17.14%)	15.15k
ALTHOMetavisio (Thomson Computing)	0.397 € (16.42%)	1.34M
IBABIon Beam Applications SA	15.00 € (14.16%)	178.95k
ALMEXMexedia SPA	6.80 € (13.33%)	64
MLWEYWeya	0.02 € (-95.45%)	10
ALAVEAventador	0.001 € (-28.57%)	35.75M
ALDVAlliance Developpement Capital Siic	0.06 € (-19.46%)	280.26k
GNROGeNeuro SA	0.0724 € (-18.65%)	28.22k
MLGRCGroupe Carnivor	16.80 € (-16.00%)	12
BCPBanco Comercial Portugues SA	0.4333 € (3.51%)	141.92M
ALAVEAventador	0.001 € (-28.57%)	35.75M
ALDOLDolfines	0.0006 € (-14.29%)	29.46M
ALRPDRapid Nutrition	0.0746 € (28.18%)	15.67M
ALNRGEnergisme SA	0.0061 € (7.02%)	12.85M

infamous

infamous 4 minutes ago

The FIRST THING they did was dilute like 150mil shares
Duh

joyceschoice

joyceschoice 4 minutes ago

Time for a few laughs. Jimmy Kimmel had a very funny night.

https://www.youtube.com/watch?v=yCc5d-eny_E

nickeli54

nickeli54 4 minutes ago

Not sure something is up here tnough

HoldEm777

HoldEm777 5 minutes ago

Good luck. I actually hope it does.

Top Penny

Top Penny 6 minutes ago

Myth

Myth 6 minutes ago

The Killers - Why Don't You Find Out for Yourself

https://www.youtube.com/watch?v=qQmjgdNan4M

Hopeforthefuture3

Hopeforthefuture3 6 minutes ago

I hope combo therapy will improve results. Certainly that is why 1 of the 3 UCLA SPORE grant trials is combination therapy including the vaccine. To become soc will require trials beyond what UCLA is doing but perhaps the docs will be smart enough to use it before the trials - but will take time

Eli's Gone

Eli's Gone 7 minutes ago

manibiotech

manibiotech 7 minutes ago

https://www.amazon.com/Keys-Comprehension-Help-Your-Kids/dp/0761515496/ref=asc_df_0761515496/?tag=hyprod-20&linkCode=df0&hvadid=693033695484&hvpos=&hvnetw=g&hvrand=13040011165710273796&hvpone=&hvptwo=&hvqmt=&hvdev=m&hvdvcmdl=&hvlocint=&hvlocphy=9031203&hvtargid=pla-489541744778&psc=1&mcid=41d1dc794d

Eli's Gone

Eli's Gone 8 minutes ago

Vexari

Vexari 8 minutes ago

fink

fink 9 minutes ago

GPLS up 60% Friday. New R/M shell. Oil&gas
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175222353

Same insiders that took Sky Wuarry public via an Nasdaq IPO this past week in SKYQ

This is not your typical stink pink play.
I'd familiari

buysellrepeat

buysellrepeat 9 minutes ago

How can someone begin to be negative on a brand new company? What purpose does that serve?

PROPHET-of-PROFITS

PROPHET-of-PROFITS 9 minutes ago

6.80 euros on the French exchange with a 40m market cap.
https://live.euronext.com/en/product/equities/IT0005450819-ALXP

Rdar is so gone. 01 isn't high enough for what is coming in rdar

Myth

Myth 10 minutes ago

very nice, I just saw the other day Raul was battling colon cancer, best wishes to him...

.love The Mavericks !

Diogenes of Sinope

Diogenes of Sinope 10 minutes ago

Good afternoon Z.

I hope you and yours are well.

Regards.

Take care✌️

manibiotech

manibiotech 10 minutes ago

BS as usual
Read my post slowly

Advent is not owned by or controlled or managed by NWBO or its shareholders . Shareholders however do pay for its private development .
Now read it slowly this time 2-3 times without cheerleading glasses and comprehend .

JFR161162

JFR161162 10 minutes ago

The broad body of evidence matters.

DOGONE

DOGONE 11 minutes ago

Thank you my friend..Your DD is amazing as always. Sorry for the late reply..I have been away.

ElectricJester54

ElectricJester54 11 minutes ago

Really appreciate you guys keeping us all in the loop here. But I'm in the same boat as fink, I'm not going anywhere for awhile but it's nice to know the short term is looking pretty good. The real fun will be the long term though and I'm glad to be a part of it.

Aquahoya

Aquahoya 12 minutes ago

Guys. Do you understand how lenders work? Look into the filings. AES and Leonite have been given shares month over month. Either their debt hasn't been paid back or they were given shares for capital. Probably shares at a .02 basis. So, every $10,000 they given, they receive 500,000 shares, if that

i_like_bb_stock

i_like_bb_stock 12 minutes ago

Looking forward to an exciting week, can tomorrow get here already!

richme

richme 12 minutes ago

We will see if the outcomes of these actions will have any near term effect on the share price.

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions